{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:02:15Z","timestamp":1791068535001,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[1990,9,1]],"date-time":"1990-09-01T00:00:00Z","timestamp":652147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1990,9,1]],"date-time":"1990-09-01T00:00:00Z","timestamp":652147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1990,9]]},"DOI":"10.1136\/ard.49.9.690","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"690-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Natural killer cell activity in Sj\u00f6gren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes."],"prefix":"10.1016","volume":"49","author":[{"given":"N.J","family":"Struyf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.W","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H","family":"Bridts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.S","family":"De Clerck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/art.1780241107","article-title":"Natural cellmediated cytotoxicity in Sj6gren's syndrome and rheumatoid arthritis","volume":"24","author":"Goto, M.; Tanimoto, K.; Chihara, T.; Horiuchi, Y.","year":"1981","unstructured":"Goto M, Tanimoto K, Chihara T, Horiuchi Y. Natural cellmediated cytotoxicity in Sj6gren's syndrome and rheumatoid arthritis. Arthritis Rhewn 1981; 24: 1377-82.","journal-title":"Arthritis Rhewn"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/art.1780230106","article-title":"Natural killer cell function in systemic lupus erythematosus","volume":"23","author":"Hoffman, T.","year":"1980","unstructured":"Hoffman T. Natural killer cell function in systemic lupus erythematosus. Arthriiis Rhewn 1980; 23: 30-5.","journal-title":"Arthriiis Rhewn"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/art.1780231108","article-title":"Natural cell mediated cytotoxicity in systemic lupus erythematosus","volume":"23","author":"Goto, M.; Tanimoto, K.; Horiuchi, Y.","year":"1980","unstructured":"Goto M, Tanimoto K, Horiuchi Y. Natural cell mediated cytotoxicity in systemic lupus erythematosus. Arthritis Rhewn 1980; 23: 1274-81.","journal-title":"Arthritis Rhewn"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0090-1229(81)90086-6","article-title":"Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus","volume":"19","author":"Karsh, J.; Dorval, G.; K, Osterland C.","year":"1981","unstructured":"Karsh J, Dorval G, Osterland C K. Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunl Immunopathol 1981; 19: 437-46.","journal-title":"Clin Immunl Immunopathol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1084\/jem.147.5.1314","article-title":"Anti-viral activity induced by culturing lymphocytes with tumor-derived or virustransformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility by target cells to lysis","volume":"147","author":"Trinchieri, G.; Santoli, D.","year":"1978","unstructured":"Trinchieri G, Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virustransformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility by target cells to lysis. J Exp Med 1978; 147: 1314-33.","journal-title":"J Exp Med"},{"key":"ref_6","first-page":"110","article-title":"Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus. Clin Exp Immunol","volume":"47","author":"Fitzharris, P.; Alcocer, J.; F, Stephens H.A.; A, Knight R.; L, Snaith M.","year":"1982","unstructured":"Fitzharris P, Alcocer J, Stephens H A F, Knight R A, Snaith M L. Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus. Clin Exp Immunol 1982; 47: 110-8."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI110484","article-title":"Studies of the functions of natural killer-interferon system in patients with Sjogren syndrome","volume":"69","author":"Minato, N.; Takeda, A.; Kano, S.; Takaku, F.","year":"1982","unstructured":"Minato N, Takeda A, Kano S, Takaku F. Studies of the functions of natural killer-interferon system in patients with Sjogren syndrome. J Clin Invest 1982; 69: 581-8.","journal-title":"J Clin Invest"},{"key":"ref_8","first-page":"11","article-title":"Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis. CGn Exp Immunol","volume":"49","author":"A, Neighbour P.; I, Grayzel A.; E, Miller A.","year":"1982","unstructured":"Neighbour P A, Grayzel A I, Miller A E. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis. CGn Exp Immunol 1982; 49: 11-21."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI110872","article-title":"Natural killer cell in systemic lupus erythematosus","volume":"71","author":"L, Sibbitt W.; M, Mathews P.; D, Bankhurst A.","year":"1983","unstructured":"Sibbitt W L, Mathews P M, Bankhurst A D. Natural killer cell in systemic lupus erythematosus. J Cli Invest 1983; 71: 1230-9.","journal-title":"J Cli Invest"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/art.1780261103","article-title":"Impaired natural killer cell function in systemic lupus erythematosus. Relationship to interleukin 2 production","volume":"26","author":"L, Sibbitt W.; L, Likar; W, Spellman C.; D, Bankhurst A.","year":"1983","unstructured":"Sibbitt W L, Likar L, Spellman C W, Bankhurst A D. Impaired natural killer cell function in systemic lupus erythematosus. Relationship to interleukin 2 production. Arthritis Rheum 1983; 26: 1316-20.","journal-title":"Arthritis Rheum"},{"key":"ref_11","first-page":"354","article-title":"Selective impairment of alphainterferon-mediated natural killer augmentation in Sjogren's syndrome: differential effects of alpha-interferon, gammainterferon, and interleukin 2 on cytolytic activity. Clin Exp Imnumol","volume":"70","author":"Takeda, A.; Minato, N.; Kano, S.","year":"1987","unstructured":"Takeda A, Minato N, Kano S. Selective impairment of alphainterferon-mediated natural killer augmentation in Sjogren's syndrome: differential effects of alpha-interferon, gammainterferon, and interleukin 2 on cytolytic activity. Clin Exp Imnumol 1987; 70: 354-63."},{"key":"ref_12","first-page":"1223","article-title":"Natural killer cell activity in the systemic connective tissue diseases","volume":"15","author":"Gonzalez-Amaro, R.; Alcocer-Varela, J.; Alarc6n-Segovia, D.","year":"1988","unstructured":"Gonzalez-Amaro R, Alcocer-Varela J, Alarc6n-Segovia D. Natural killer cell activity in the systemic connective tissue diseases. J Rhewnatol 1988; 15: 1223-8.","journal-title":"J Rhewnatol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0022-1759(86)90258-9","article-title":"A fluorescence NK assay using flow cytometry","volume":"86","author":"McGinnes, K.; Chapman, G.; Marks, R.; Penny, R.","year":"1986","unstructured":"McGinnes K, Chapman G, Marks R, Penny R. A fluorescence NK assay using flow cytometry. J Immunol Methods 1986; 86: 7-15.","journal-title":"J Immunol Methods"},{"key":"ref_14","first-page":"78","article-title":"A simple technique using FACS analyser for determination of natural killer cell activity (NKCA). Alergologia e Immunologia Clinica","volume":"2","author":"W, Snoeck H.; M, Martin; L, Gigase P.; H, Bridts C.; S, De Clerck L.; J, Stevens W.","year":"1987","unstructured":"Snoeck H W, Martin M, Gigase P L, Bridts C H, De Clerck L S, Stevens W J. A simple technique using FACS analyser for determination of natural killer cell activity (NKCA). Alergologia e Immunologia Clinica 1987; 2: 78."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.1780290501","article-title":"Sj6gren's syndrome: proposed criteria for classification","volume":"29","author":"I, Fox R.; A, Robinson C.; G, Curd J.; F, Kozin; V, Howell F.","year":"1986","unstructured":"Fox R I, Robinson C A, Curd J G, Kozin F, Howell F V. Sj6gren's syndrome: proposed criteria for classification. Arthritis Rhewn 1986; 29: 577-85.","journal-title":"Arthritis Rhewn"},{"key":"ref_16","first-page":"1271","article-title":"revised criteriafor the classification ofsystemic lupus erythematosus","volume":"25","author":"M, Tan E.; S, Cohen A.; F, Fries J.","year":"1982","unstructured":"Tan E M, Cohen A S, Fries J F, et al. The 1982 revised criteriafor the classification ofsystemic lupus erythematosus. Arthritis Rheun 1982; 25: 1271-7.","journal-title":"The"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous cellline with positive Philadelphia chromosome","volume":"45","author":"C, Lozzio B.; B, Lozzio B.","year":"1975","unstructured":"Lozzio B C, Lozzio B B. Human chronic myelogenous cellline with positive Philadelphia chromosome. Blood 1975; 45: 321-34.","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-2478(81)90086-9","article-title":"A method for rapid determination of IgG-containing circulating immune complexes using polyethyleneglycol and radioactively labeled protein A","volume":"3","author":"J, Stevens W.; H, Bridts C.","year":"1981","unstructured":"Stevens W J, Bridts C H. A method for rapid determination of IgG-containing circulating immune complexes using polyethyleneglycol and radioactively labeled protein A. Immunol Leu 1981; 3: 1-4.","journal-title":"Immunol Leu"},{"key":"ref_19","first-page":"32","article-title":"Role of IgM-rheumatoid factor interference in the determination of total serum IgE and IgE-containing circulating immnune complexes. Clin Exp Immunol","volume":"72","author":"S, De Clerck L.; L, Gigase P.; H, Bridts C.; J, Stevens W.","year":"1988","unstructured":"De Clerck L S, Gigase P L, Bridts C H, Stevens W J. Role of IgM-rheumatoid factor interference in the determination of total serum IgE and IgE-containing circulating immnune complexes. Clin Exp Immunol 1988; 72: 32-6."},{"key":"ref_20","first-page":"507","article-title":"Natural killer cells in connective tissue disorders","volume":"11","author":"L, Sibbitt W.; D, Bankhurst A.","year":"1985","unstructured":"Sibbitt W L, Bankhurst A D. Natural killer cells in connective tissue disorders. Clin Rhewn Dis 1985; 11: 507-21.","journal-title":"Clin Rhewn Dis"},{"key":"ref_21","first-page":"1","article-title":"Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sj6gren's syndrome. Clin Exp Immunol","volume":"63","author":"K, Pedersen B.; P, Oxholm; R, Manthorpe; V, Andersen","year":"1986","unstructured":"Pedersen B K, Oxholm P, Manthorpe R, Andersen V. Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sj6gren's syndrome. Clin Exp Immunol 1986; 63: 1-7."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/art.1780280213","article-title":"Circulating natural killer cells in Sjogren's syndrome","volume":"28","author":"Ichikawa, Y.; Yoshida, M.; Takaya, M.; Uchiyama, M.; Shimizu, H.; Arimori, S.","year":"1985","unstructured":"Ichikawa Y, Yoshida M, Takaya M, Uchiyama M, Shimizu H, Arimori S. Circulating natural killer cells in Sjogren's syndrome. Arthitis Rheum 1985; 28: 182-7.","journal-title":"Arthitis Rheum"},{"key":"ref_23","first-page":"576","article-title":"Interferon production in vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Immunol","volume":"45","author":"A, Neighbour P.; I, Grayzel A.","year":"1981","unstructured":"Neighbour P A, Grayzel A I. Interferon production in vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Immunol 1981; 45: 576-82."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1172\/JCI110579","article-title":"Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus","volume":"69","author":"Alcocer-Varela, J.; Alarc6n-Segovia, D.","year":"1982","unstructured":"Alcocer-Varela J, Alarc6n-Segovia D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 1982; 69: 1388-92.","journal-title":"J Clin Invest"},{"key":"ref_25","first-page":"952","article-title":"Partial purification and characterization of systemic lupus erythematosus derived factors that suppress production of interleukin 2","volume":"15","author":"Linker-Israeli, M.; Casteel, N.","year":"1988","unstructured":"Linker-Israeli M, Casteel N. Partial purification and characterization of systemic lupus erythematosus derived factors that suppress production of interleukin 2. J Rheumatol 1988; 15: 952-8.","journal-title":"J Rheumatol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0090-1229(84)90195-8","article-title":"Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus","volume":"31","author":"Miyasaka, N.; Nakamura, T.; J, Russell I.; Talal, N.","year":"1984","unstructured":"Miyasaka N, Nakamura T, Russell I J, Talal N. Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immwnol Immnopathol 1984; 31: 109-17.","journal-title":"Clin Immwnol Immnopathol"},{"key":"ref_27","first-page":"246","article-title":"Interferon and natural killer cells in systemic lupus erythematosus. Clin Exp Immunol","volume":"50","author":"Strannegard 0, Hermodsson S, Westberg G","year":"1982","unstructured":"Strannegard 0, Hermodsson S, Westberg G. Interferon and natural killer cells in systemic lupus erythematosus. Clin Exp Immunol 1982; 50: 246-52."},{"key":"ref_28","first-page":"239","article-title":"Natural killer cells and interferon responses in patients with systemic lupus erythematosus. Clin Exp Immunol","volume":"50","author":"C, Tsokos G.; H, Rook A.; Y, Djeu J.; B, Balow J.","year":"1982","unstructured":"Tsokos G C, Rook A H, Djeu J Y, Balow J B. Natural killer cells and interferon responses in patients with systemic lupus erythematosus. Clin Exp Immunol 1982; 50: 239-45."},{"key":"ref_29","first-page":"562","article-title":"Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol","volume":"70","author":"Kim, T.; Kanayama, Y.; Negoro, N.; Okamura, M.; Inoue, Takeda T.; T.","year":"1987","unstructured":"Kim T, Kanayama Y, Negoro N, Okamura M, Takeda T. Inoue T. Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol 1987; 70: 562-9."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/art.1780280605","article-title":"Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus","volume":"28","author":"L, Sibbitt W.; L, Gibbs D.; C, Kenny; D, Bankhurst A.; P, Searles R.; D, Ley K.","year":"1985","unstructured":"Sibbitt W L, Gibbs D L, Kenny C, Bankhurst A D, Searles R P, Ley K D. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus. Arthritis Rhewn 1985; 28: 624-9.","journal-title":"Arthritis Rhewn"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/art.1780260508","article-title":"Natural killer cells in systemic lupus erythematosus: abnormal numbers and functional immaturity of HNK-1 cells","volume":"26","author":"L, Egan M.; L, Mendelson S.; T, Abo; M, Balch C.","year":"1983","unstructured":"Egan M L, Mendelson S L, Abo T, Balch C M. Natural killer cells in systemic lupus erythematosus: abnormal numbers and functional immaturity of HNK-1 cells. Arthritis Rheum 1983; 26: 623-9.","journal-title":"Arthritis Rheum"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.4049\/jimmunol.139.4.1070","article-title":"Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus","volume":"139","author":"Ishida, H.; Kumagai, S.; Umehara, H.","year":"1987","unstructured":"Ishida H, Kumagai S, Umehara H, et al. Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus. J Immunol 1987; 139: 1070-4.","journal-title":"J Immunol"},{"key":"ref_33","first-page":"3","article-title":"Interleukin 2 receptors and responsiveness to recombinant hulman interleukin 2 in patients with systemic lupus erythematosus","volume-title":"Mayo Clin Proc","volume":"62","author":"Lakhanpal, S.; Handwerger, B.","year":"1987","unstructured":"Lakhanpal S, Handwerger B. Interleukin 2 receptors and responsiveness to recombinant hulman interleukin 2 in patients with systemic lupus erythematosus. Mayo Clin Proc 1987; 62: 3-7."},{"key":"ref_34","first-page":"363","volume":"53","author":"L, Sibbitt W.; J, Froelich C.; D, Bankhurst A.","year":"1983","unstructured":"Sibbitt W L, Froelich C J, Bankhurst A D. Natural coyftostuopxipcrietsysiionnsybsytemiinchilbuiptoursyersyetrhuemmatfoascutsor:s.meGclhianniEsxmps Immunol 1983; 53: 363-70.","journal-title":"Natural coyftostuopxipcrietsysiionnsybsytemiinchilbuiptoursyersyetrhuemmatfoascutsor:s.meGclhianniEsxmps Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724116172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724116172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.49.9.690","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:22:36Z","timestamp":1738304556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724116172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1990,9]]}},"alternative-id":["S0003496724116172"],"URL":"https:\/\/doi.org\/10.1136\/ard.49.9.690","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1990,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cell activity in Sj\u00f6gren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.49.9.690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1990 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}